Monoclonal or polyclonal IgM antibodies that react with the same gangliosides as the IgG antibodies in GBS are associated with chronic neuropathy syndromes that otherwise resemble the acute GBS phenotypes [43,44]. This evidence concerns the gene CD40LG and Guillain-Barre syndrome.